PL2055718T3 - Ukierunkowywanie i śledzenie antygenów w żywych komórkach - Google Patents

Ukierunkowywanie i śledzenie antygenów w żywych komórkach

Info

Publication number
PL2055718T3
PL2055718T3 PL08019358T PL08019358T PL2055718T3 PL 2055718 T3 PL2055718 T3 PL 2055718T3 PL 08019358 T PL08019358 T PL 08019358T PL 08019358 T PL08019358 T PL 08019358T PL 2055718 T3 PL2055718 T3 PL 2055718T3
Authority
PL
Poland
Prior art keywords
tracing
antigens
targeting
living cells
living
Prior art date
Application number
PL08019358T
Other languages
English (en)
Inventor
Ulrich Rothbauer
Heinrich Leonhardt
Original Assignee
Ludwig Maximilians Univ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ludwig Maximilians Univ filed Critical Ludwig Maximilians Univ
Publication of PL2055718T3 publication Critical patent/PL2055718T3/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43595—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from coelenteratae, e.g. medusae
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/22—Immunoglobulins specific features characterized by taxonomic origin from camelids, e.g. camel, llama or dromedary
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/60—Fusion polypeptide containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PL08019358T 2005-11-11 2006-11-13 Ukierunkowywanie i śledzenie antygenów w żywych komórkach PL2055718T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05024739A EP1785434A1 (en) 2005-11-11 2005-11-11 Targeting and tracing of antigens in living cells
EP20060818501 EP1945673B1 (en) 2005-11-11 2006-11-13 Targeting and tracing of antigens in living cells
EP08019358A EP2055718B1 (en) 2005-11-11 2006-11-13 Targeting and tracing of antigens in living cells

Publications (1)

Publication Number Publication Date
PL2055718T3 true PL2055718T3 (pl) 2013-05-31

Family

ID=36580398

Family Applications (2)

Application Number Title Priority Date Filing Date
PL06818501T PL1945673T3 (pl) 2005-11-11 2006-11-13 Ukierunkowywanie i śledzenie antygenów w żywych komórkach
PL08019358T PL2055718T3 (pl) 2005-11-11 2006-11-13 Ukierunkowywanie i śledzenie antygenów w żywych komórkach

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL06818501T PL1945673T3 (pl) 2005-11-11 2006-11-13 Ukierunkowywanie i śledzenie antygenów w żywych komórkach

Country Status (7)

Country Link
US (2) US20090136934A1 (pl)
EP (3) EP1785434A1 (pl)
CA (1) CA2628388C (pl)
DK (2) DK2055718T3 (pl)
ES (2) ES2542337T3 (pl)
PL (2) PL1945673T3 (pl)
WO (1) WO2007068313A2 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2078750T3 (da) * 2008-01-09 2017-01-02 Univ Muenchen Ludwig Maximilians Fluorescerende to-hybrid (F2H) assay til direkte visualisering af proteininteraktioner i levende celler
EP2275442A1 (en) * 2009-07-06 2011-01-19 Ludwig-Maximilians-Universität München Detection and vizualization of the cell cycle in living cells
ES2609313T3 (es) 2011-06-29 2017-04-19 Affinity Biosciences Pty Ltd Método de expresión de proteínas
EP2685260A1 (en) * 2012-07-09 2014-01-15 Ludwig-Maximilians-Universität München Direct and quantitative detection of targets in living cells
FR3007411B1 (fr) * 2013-06-21 2015-07-03 Agronomique Inst Nat Rech Anticorps monocatenaire a chaine lourde de camelide dirige contre la chromatine et utilisations
US20170212130A1 (en) * 2014-06-25 2017-07-27 The Rockefeller University Compositions and methods for rapid production of versatile nanobody repertoires
US10782304B2 (en) 2015-06-24 2020-09-22 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for detecting protein-protein interactions
CN110759997A (zh) * 2018-07-27 2020-02-07 深圳康体生命科技有限公司 一种gfp抗体的制备方法及其抗体
CN110759996B (zh) * 2018-07-27 2022-09-06 深圳康体生命科技有限公司 一种gfp抗体
CN110759999A (zh) * 2018-07-27 2020-02-07 深圳康体生命科技有限公司 一种gfp抗体制备方法及其载体
CN110759998A (zh) * 2018-07-27 2020-02-07 深圳康体生命科技有限公司 一种gfp抗体制备方法及其dna序列
CA3161024A1 (en) * 2019-12-19 2021-06-24 Quidel Corporation Monoclonal antibody fusions

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0232262A4 (en) 1985-08-15 1989-09-19 Stauffer Chemical Co MICROORGANISM PRODUCING TRYPTOPHANE.
IL86724A (en) 1987-06-19 1995-01-24 Siska Diagnostics Inc Methods and kits for amplification and testing of nucleic acid sequences
DK0464533T3 (da) 1990-06-28 1999-04-26 Gen Hospital Corp Fusionsproteiner med immunglobulindele, deres fremstilling og anvendelse
US5625048A (en) 1994-11-10 1997-04-29 The Regents Of The University Of California Modified green fluorescent proteins
DE69604298T2 (de) 1995-09-22 2000-05-18 Bioimage A/S, Soeborg Varianten des grünen fluoreszenzproteins, gfp
WO1998031700A1 (en) 1997-01-21 1998-07-23 The General Hospital Corporation Selection of proteins using rna-protein fusions
US6261804B1 (en) 1997-01-21 2001-07-17 The General Hospital Corporation Selection of proteins using RNA-protein fusions
CA2324648C (en) * 1998-03-27 2013-02-26 Prolume, Ltd. Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items
US6414119B1 (en) 1998-10-16 2002-07-02 Rutgers, The State University Rapidly greening, low oxygen mutant of the aequoria victoria green fluorescent protein
AUPP846399A0 (en) 1999-02-02 1999-02-25 University Of Sydney, The Pigment protein from coral tissue
US6281223B1 (en) 1999-04-13 2001-08-28 Supergen, Inc. Radioenhanced camptothecin derivative cancer treatments
US20030013849A1 (en) 1999-10-29 2003-01-16 Ward William W. Renilla reniformis green fluorescent protein
AU2001279669B2 (en) 2000-06-19 2006-02-02 Bioimage As Fluorescent proteins
EP1433793A4 (en) * 2001-09-13 2006-01-25 Inst Antibodies Co Ltd METHOD FOR CREATING A CAMEL ANTIBODY LIBRARY
US20030203355A1 (en) 2002-04-24 2003-10-30 Los Alamos National Laboratory Fluorobodies: binding ligands with intrinsic fluorescence
FR2846667B1 (fr) * 2002-11-06 2004-12-31 Pasteur Institut Fragments variables d'anticorps de camelides a chaine unique diriges contre le peptide beta-amyloide 1-42 et leurs applications pour le diagnostic et le traitement des maladies neuroagregatives
EP2267032A3 (en) * 2002-11-08 2011-11-09 Ablynx N.V. Method of administering therapeutic polypeptides, and polypeptides therefor
AU2004205631A1 (en) * 2003-01-16 2004-08-05 Genentech, Inc. Synthetic antibody phage libraries
BRPI0518151A2 (pt) * 2004-10-13 2009-06-16 Ablynx Nv polipetìdeos contra amiloide-beta, ácido nucléico que codifica tal polipetìdeo, composição compreendendo tal polipetìdeo, método para produzir um polipetìdeo e uso do mesmo

Also Published As

Publication number Publication date
EP2055718A1 (en) 2009-05-06
EP1945673A2 (en) 2008-07-23
PL1945673T3 (pl) 2015-10-30
DK1945673T3 (en) 2015-07-13
CA2628388C (en) 2018-06-05
CA2628388A1 (en) 2007-06-21
WO2007068313A3 (en) 2007-09-13
EP1785434A1 (en) 2007-05-16
ES2542337T3 (es) 2015-08-04
WO2007068313A2 (en) 2007-06-21
US20130323747A1 (en) 2013-12-05
DK2055718T3 (da) 2013-04-02
EP1945673B1 (en) 2015-05-06
ES2401359T3 (es) 2013-04-18
US20090136934A1 (en) 2009-05-28
EP2055718B1 (en) 2012-12-26

Similar Documents

Publication Publication Date Title
PL2055718T3 (pl) Ukierunkowywanie i śledzenie antygenów w żywych komórkach
SI2287195T1 (sl) Pan-kir2dl nk-receptor protitelesa in njihova uporaba pri diagnostiki in terapiji
ZA200803153B (en) Antibody-drug conjugates and methods of use
HRP20140271T1 (hr) Humana antitijela protiv bjesnoä†e i njihova uporaba
IL188420A0 (en) Methods and compositions with enhanced therapeutic activity
EP2064550A4 (en) PRRG4 ASSOCIATED COMPOSITIONS AND METHOD FOR USE THEREOF FOR TUMOR DIAGNOSTIC PROCEDURES
EP1778210A4 (en) CONJUGATES OF FATTY ACID AND AMINO ACIDS AND METHODS OF USE
GB0514891D0 (en) Improvements in and relating to implants
EP1802740A4 (en) TRANSGENIC STRAINS OF TRICHODERMA AND THEIR USE IN BIOLOGICAL CONTROL
HK1148026A1 (en) Novel rubella e1 envelope protein variants and their use in the detection of antirubella antibodies e1
GB0605893D0 (en) Improvements In And Relating To Providing Information
EP1932496A4 (en) STENT FOR PLACEMENT IN THE LIVING BODY
GB0406835D0 (en) Improvements in and relating to implants
GB0516962D0 (en) Improvements in and relating to investigations
GB0606484D0 (en) Improvements in and relating to instruments
GB0718156D0 (en) Improvements in and relating to investigations
EP1930406A4 (en) IN THE BRAIN WALKING CELL AND USE THEREOF
GB0505908D0 (en) Antibodies and their use in therapy
GB0424871D0 (en) Antibodies and their use in therapy
GB0515205D0 (en) Low density gel concept and application
GB0502287D0 (en) Improvements in and relating to implants
GB0506486D0 (en) Improvements in and relating to providing information
GB0506078D0 (en) Improvements in and relating to providing information
GB0605919D0 (en) Improvements in and relating to providing information
TWI316995B (en) Improvements in and relating to drivelines